Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

DES Home | For Consumers | For Health Care Providers
For DES Update Partners | Contact Us
DES Update: Health Care Providers
DES Update: Health Care Providers

Notice! Content may be out of date
The following content is no longer maintained and may be out of date. Persons with disabilities having difficulty accessing the information on this page may contact for assistance. Please view the Updated Bibliographies on the Updated Bibliographies page for updated information on this topic.

 Health Care Providers Home
 Information to Identify and Manage DES Patients
 Supplemental DES Materials for Nurses
 DES Brand Names
 Resources and Educational Tools
 DES References
 References By Number
 References By Topic

Email this page
Order DES materials
Image of a book with a page being turned  DES References
Health Care Providers Home > DES References > General

References By Topic

 Women Prescribed DES While Pregnant
 Women Exposed to DES In Utero (DES Daughters)
 Men Exposed to DES In Utero (DES Sons)
 Third Generation (the Offspring of DES Daughters and Sons)

285. Cohn BA, Wingard DL, Patterson RC, McPhee SJ, Gerbert B. The National DES Education Program: effectiveness of the California Health Provider Intervention. J Cancer Educ 2002 Spring;17(1):40-5.

286. Department for Policy Coordination and Sustainable Development. Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by government. 6th ed. Pharmaceuticals. New York: United Nations; 1997.

287. Federal Drug Administration. Federal Register 1971;36:21537.

288. Jackson R, O'Donnell L, Johnson C, Dietrich AJ, Lauridsen J, O'Donnell C. Office systems intervention to improve diethylstilbestrol screening in managed care. Obstet Gynecol 2000;96(3):380-4.

289. Kaufman RH, Adam E, Haynes SG, Herbst AL, Kutzner SK, McPhee SJ, et al. Physician information: how to identify and manage DES exposed individuals. Bethesda, MD: National Cancer Institute; 1995.

290. National Cancer Institute. Exposure in utero to diethylstilbestrol and related synthetic hormones. JAMA 1976;236(10):1107-9.

291. National Cancer Institute. Cancer Facts: Questions and Answers about DES. Bethesda, MD: NCI; 2000. Available from:

292. National Cancer Institute. Dictionary. Available from

293. National Institutes of Health. DES Research Update. Bethesda, MD: NIH; 1999.

294. National Cancer Institute, National Institute of Environmental Health Sciences, Office of Research on Women's Health, US Public Health Service's Office on Women's Health, Centers for Disease Control and Prevention. DES research update: Current knowledge, future directions. Proceedings. Bethesda, MD: NIH; 1999.

295. National Institutes of Health. NIH Workshop: Long-term effects of exposure to diethylstilbestrol (DES). Bethesda, MD: NIH; 1992.

296. Robboy SJ, Noller KL, Kaufman RH, Barnes AB, Townsend D, Gundersen JH, et al. Information for physicians: an atlas of findings in the human female after intrauterine exposure to diethylstilbestrol. Bethesda, MD: National Institutes of Health; 1983.

297. Wingard DL, Cohn BA, Helmrich SP, Edelstein SL. DES awareness and exposure: the 1994 California Behavioral Risk Factor Survey. Am J Prev Med 1996;12(5):437-41.

Back to Top

Contact Us | Site Map | Privacy Policy | Disclaimer | FOIA | Accessibility

CDC Home | Search | Health Topics A-Z

United States Department of Health and Human Services
Centers for Disease Control and Prevention